Hyaluronic acid conjugated graphene oxide for targeted drug delivery
Authors:
- Huixia WuHWHuixia Wu
- Haili ShiHSHaili Shi
- Yapei WangYWYapei Wang
- Xiaoqing JiaXJXiaoqing Jia
- Caizhi TangCTCaizhi Tang
- Jiamin ZhangJZJiamin Zhang
- Shiping YangSYShiping Yang
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (21271130)
- Shanghai Natural Science Foundation (13ZR1430300)
- Shanghai Municipal Education Commission (14ZZ128)
- Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure (SKL201212SIC)
This publication has 57 references indexed in Scilit:
- Hyaluronic acid-conjugated graphene oxide/photosensitizer nanohybrids for cancer targeted photodynamic therapyJournal of Materials Chemistry B, 2013
- In situ gelation and sustained release of an antitumor drug by graphene oxide nanosheetsCarbon, 2012
- Cytotoxicity of Graphene Oxide and Graphene in Human Erythrocytes and Skin FibroblastsACS Applied Materials & Interfaces, 2011
- Intracellular Imaging with a Graphene‐Based Fluorescent ProbeSmall, 2010
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivoJournal of Controlled Release, 2007
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Preparation of Graphitic OxideJournal of the American Chemical Society, 1958